AbSci Corp (ABSI): Price and Financial Metrics
GET POWR RATINGS... FREE!
ABSI Stock Price Chart Interactive Chart >
ABSI Price/Volume Stats
|Current price||$3.50||52-week high||$31.53|
|Prev. close||$3.53||52-week low||$3.32|
|Day high||$3.74||Avg. volume||1,146,472|
|50-day MA||$6.69||Dividend yield||N/A|
|200-day MA||$10.58||Market Cap||324.98M|
AbSci Corp (ABSI) Company Bio
Absci Corporation, an AI-powered synthetic biology company, offers biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. The company was founded in 2011 and is headquartered in Vancouver, Washington.
Most Popular Stories View All
ABSI Latest News Stream
|Loading, please wait...|
ABSI Latest Social Stream
View Full ABSI Social Stream
Latest ABSI News From Around the Web
Below are the latest news stories about Absci Corp that investors may wish to consider to help them evaluate ABSI as an investment opportunity.
VANCOUVER, Wash., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins, today announced the company will be participating virtually in the following investor conferences. Truist Life Sciences AI Symposium – Biotech & ToolsPanel Discussion on Tuesday, March 1st at 7:10 a.m. Pacific Time / 10:10 a.m. Eastern TimeInterested parties may view the Sympo
In the last trading session, 1.42 million shares of the Absci Corporation (NASDAQ:ABSI) were traded. Most recently the company’s share price was $8.83, and it changed around $0.05 or 0.57% from the last close, which brings the market valuation of the company to $799.73M. ABSI currently trades at a discount to its 52-week high of … Future Outlook And Stock Price Performance For Absci Corporation (NASDAQ: ABSI) Read More »
Absci to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
VANCOUVER, Wash., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins, today announced the company will be participating virtually in the upcoming BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference.
The following slide deck was published by Absci Corporation in conjunction with this event.
Regulatory and other pipeline updates from Biogen (BIIB) and AMGN are among a few key highlights from the biotech sector during the past week.
ABSI Price Returns